DocDollars

Mayne Pharma Commercial LLC

NC · United States · Reporting entity ID 100000136519

Total reported 2019–2025
$8.99M
#526 of 2,960 reporting companies — 0% of all reported industry payments
$7.08M in general payments across 209,187 records, plus $1.91M in research funding across 94 records.

How it breaks down

General payments $7,077,436
Research funding $1,911,011

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Mayne Pharma Commercial LLC reported $8.99M to US doctors and teaching hospitals from 2019 to 2025, ranking #526 of 2,960 reporting companies. 21% of that was research funding and 79% general payments such as consulting, speaking, food and travel. 209,187 general payment records and 94 research records were filed.

Common questions about Mayne Pharma Commercial LLC

How much has Mayne Pharma Commercial LLC paid US doctors?

Mayne Pharma Commercial LLC reported $8,988,448 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,077,436 in general payments, $1,911,011 in research funding.

How does Mayne Pharma Commercial LLC rank among drug and device companies?

It ranks #526 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Mayne Pharma Commercial LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.